Januvia Re-examination Study (MK-0431-181)

NCT01062048 · clinicaltrials.gov ↗

COMPLETED

Status

3483

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Sulfonylurea
BIOLOGICAL: Insulin

Sponsor

Merck Sharp & Dohme LLC